Information Technology Solu-

RICK SCOTT

Governor

JOHN H. ARMSTRONG, MD, FACS

Surgeon General & Secretary Florida Department of Health

REBECCA POSTON, BPharm, MHL

Program Manager

2012-2013 Prescription Drug Monitoring Program

Annual Report

December 1, 2013

Rick Scott Governor John H. Armstrong, MD, FACS State Surgeon General & Secretary Rebecca Poston, BPharm, MHL Program Manager E-FORCSE® 4052 Bald Cypress Way, Bin C-16 Tallahassee, FL 32399 (850) 245-4444 x 3700

Executive

Introduct

What Are

Legal Fra

History

Summ

Summ

Florida P

Prescript

Performa

1.  Odepart

2.  Oby indi

3.  Omonito

4.  Osafety

Effective

Reduc

PDMP

Conclusi

 

e Summary 

tion ...............

e Prescriptio

amework .....

y of Legislati

ary of Statut

ary of Admin

PDMP Fundi

tion Drug Mo

ance Measu

UTCOME: Rment educa

UTCOME: Rviduals. ......

UTCOME: Inoring program

UTCOME: Inand reductio

ness of Flor

cing Doctor S

Survey ......

on ................

Pres

.....................

.....................

on Drug Mon

.....................

ion ...............

te .................

nistrative Ru

ng ................

onitoring Sys

res ...............

Reduction otion and saf

Reduction of.....................

ncreased com. .................

nvolvement on of prescri

rida’s PDMP

Shopping .....

.....................

.....................

cription Dru2012-201

Table

.....................

.....................

nitoring Prog

.....................

.....................

.....................

ules ...............

.....................

stem Enhan

.....................

f the rate of fety efforts. ..

f the quantity.....................

oordination a.....................

of stakeholdiption drug a

 ....................

.....................

.....................

.....................

ug Monitori3 Annual R

e of Content

......................

......................

rams? ..........

......................

......................

......................

......................

......................

cements ......

......................

inappropriat......................

y of pharmac......................

among partn......................

ders in achieabuse and p

......................

......................

......................

......................

ing ProgramReport

ts

.....................

.....................

.....................

.....................

.....................

.....................

.....................

.....................

.....................

.....................

te use of pre.....................

ceutical cont.....................

ers participa.....................

eving improvrescription d

.....................

.....................

.....................

.....................

m

.....................

.....................

.....................

.....................

.....................

.....................

.....................

.....................

.....................

.....................

escription dr.....................

trolled subst.....................

ating in the p.....................

ved patient hdrug diversio

.....................

.....................

.....................

.....................

......................

......................

......................

......................

......................

......................

......................

......................

......................

......................

rugs through......................

tances obtai......................

prescription ......................

health care aon. .................

......................

......................

......................

......................

 

....... 2 

....... 3 

....... 4 

....... 5 

....... 5 

....... 6 

....... 7 

....... 8 

....... 8 

....... 8 

h ....... 9 

ined ..... 10 

drug ..... 15 

and ..... 20 

..... 20 

..... 21 

..... 22 

..... 24 

 

 

The 2012misuse aimplemensecurity aDepartmeprivacy st The PDMhealth of saves thedecreasinprescripti Today, ththe databmillion reenforcemto assist i Florida haFORCSErecent DOsubstancDeceasedoxycodonto 2011. and methpatient redecrease It is encoand utilizapractice. E-FORCSdoctor shprescribinmade, the

Mes

2-2013 Annuand diversion ntation. An eand guardrailent has collatakeholders t

MP’s goals arall people in

e lives of thosng diversion oon drug abus

here are overbase. In the fiquests to vie

ment has requin active crim

as seen promE®; Drugs IdeOH survey ree prescribingd Persons byne plunged 4In addition, p

hadone, fell bequesting andes during the

uraging that,ation increas

SE® has provhopping and cng, dispensinere is no finis

ssage from

al Report higof controlled

effective PDMs for data usborated with to strengthen

e integrally aFlorida throu

se with prescof controlled se epidemic

r 87 million coirst two years

ew their specuested and reminal investig

mising resultsentified in Deesults supporg and addresy Florida Med1 percent in prescriptionsby 24 percentd receiving preporting pe

through edused 61 perce

ven to be an controlled sung, and use osh line until p

m the State

ghlights the ad substance pMP requires rse following a

law enforcemn policies tha

aligned with Dugh integratecription narcosubstances,in our state.

ontrolled subs of operationific patient’s eceived moreations involv

s since the imeceased Persrt the effectivssing the presdical Examin2012, and ov

s for two of tht and 8 perce

prescriptionsriod.

ucational effont, suggestin

effective toobstance rela

of controlled sprescription d

e Surgeon

accomplishmeprescription dreliable privaauthorized rement agencie

at protect hea

DOH’s missioed state, couotic addiction, and assistin

bstance prescn, physicianscontrolled su

e than 33,000ving controlle

mplementatiosons by Floriveness of E-Fscription drug

ners 2012 Reverall drug de

he four most ent respectivefrom multiple

orts, E-FORCng it is becom

l used to proated deaths, wsubstances.

drug abuse is

John Surg

General &

ents of the Pdrugs in the pcy protection

elease from thes, the Attornalth informati

on to protectnty, and com

n by improvinng interagenc

cription dispes and pharmaubstance disp0 investigativ

ed substance

on of E-FORCida Medical EFORCSE® asg abuse epid

eport, shows eaths fell by harmful presely. Doctor se physicians

CSE® registraming an integ

otect public hewhile supporWhile promi

s eliminated i

n H. Armstrogeon Genera

& Secretary

PDMP in reduprogram’s sens that includhe databaseney General’on.

, promote, anmmunity efforng clinical deccy efforts to c

ensing recordacists made pensing histove reports fro

es.

CSE®. Data Examiners 20s a tool in imdemic. Drugsthat deaths c10 percent w

scription drugshopping, desimultaneou

ation increasegral part of ro

ealth and safrting sound csing progresin Florida.

ng, MD, FACal & Secretary

y

ucing abuse, econd full yeade database . This year, ’s office, and

nd improve thrts. The PDMcision-makincurb the

ds maintainemore than 6ory. Law om program s

from E-012 Report; aproving cont

s Identified incaused by when compags, oxycodonefined as, a sly also show

ed 28 percenoutine clinical

fety by reducclinical ss has been

CS y 

1 

 

ar of

the d

he MP g,

ed in .4

staff

and rolled

n

red ne

wed

nt l

cing

 

 As requirhighlightsthe rate oreductionattemptinparticipatcare and The Floriof contro893.055,controlleddays of dinformatidatabasehighly abwho are substanc The PDMreceivingHealth caLaw enfoactive inv Since imsubstancpharmacprior yeaprescriptalso by aof 2,000 FORCSE The effecFlorida Mby almosthe PDMprescript

red by sectios the accomof inapproprn of the quanng to engageting in the P safety and

ida PDMP wolled substan

F.S., directed substance

dispensing con is intendee to health cabused prescr“doctor shop

ce from mult

MP, called E-g controlled sare practitionorcement agvestigations

plementatioce prescriptiocists queried r. Evidence ion drug abu

a 28 percent PDMP users

E® to inform

ctiveness of Medical Examst 41 percentP documentions from fiv

on 893.055(8plishments oiate use of pntity of pharme in fraud anDMP; and inreduction of

was created bnces and to red DOH to e

e prescriptionontrolled sued to provideare practitioription drugspping” or tryiiple health c

-FORCSE®, substance dners began aencies begaon Novemb

n of Florida’ons to the Ethese recorof the value

use, misuse increase in

s surveyed ttheir control

the PDMP iminers 2012t in 2012, anted a 51 perve or more p

Execut

8), Florida Sof the PDMPprescription dmaceutical cnd deceit; incnvolvement of prescription

by the 2009 reduce drug establish a cn informationbstances to e controlled ners to guid

s.  It also assing to obtain

care practitio

became opispensing daaccessing than requestingber 14, 2011

s PDMP, dis-FORCSE®

rds more thae of the PDM

and diversiohealth care

this year tholed substan

s reflected i2 Report whicnd overall drrcent decreaprescribers a

tive Summ

Statutes (F.SP in achievindrugs througcontrolled sucreased cooof stakeholdn drug divers

Florida Legabuse and

comprehensin from healtha patient. Itsubstance de their decis

sists health cn multiple preoners, a felon

erational onata from phahe data repog PDMP inv.

spensers hadatabase. I

an 3.7 millionMP as a clinicon is supporpractitioner

ought all presce prescribin

n the Drugs ch shows thaug deaths fese in the nu

and five or m

mary

S.), the 2012-ng the followgh DOH eduubstances obordination amders in achiesion.

islature to ediversion wiive databaseh care practts use is notdispensing insions in prescare practitioescriptions fny in the sta

n Septemberarmacies anorted to the Pvestigative re

ave reported n the last ye

n times, a 61cal decision rted not onlyregistration

scribers andng and dispe

Identified inat deaths caell by 9.9 pember of indi

more pharma

-2013 PDMPwing outcomeucation and sbtained by inmong intereseving improv

encourage saithin the State system thatitioners witht mandatory.nformation c

scribing and oners in idenfor the sameate of Florida

r 1, 2011, whd dispensingPDMP on Oceports during

over 87 millear, physicia1 percent incmaking tool

y by the incre. Additional

d dispensersensing clinic

n Deceased aused by oxyrcent. In theividuals rece

acies in a 90-

P Annual Rees: reductionsafety effortsndividuals sted parties ved patient h

afer prescribte. Section at collects hin seven (7). The collected in tdispensing

ntifying patiee controlled a.

hen it begang practitionectober 17, 2g the course

lion controlleans and crease over l to reduce eased usagely, 82.8 perc

s should use cal decisions

Persons by ycodone plue same perioeiving -day period.

2 

 

eport n of s;

ealth

bing

)

the

ents

n ers. 011.

e of

ed

the

e, but cent E-

s.

unged od,

 

 Backgro The CenepidemicUnited S“the intenfor the exNarcoticsthe Office“in 2010 Orders Swere locadiverted prescriptAbuse RFlorida’s effectivelabuse haFlorida w

In an initsubstancsigned SMonitorinwhile, theFlorida w

As part ocommunGovernoGerald BOfficer adeclaratioFlorida.

On SepteFlorida Ocontrolledcare pracenforceminvestiga

 

 

ound

ters for Disec.1 Florida istates. The Nntional use oxperience ors Control, Ree of Nationathe Drug En

System (ARCated in the sprescription ion drug abuoadmap 201fastest grow

ly and compas contributewas attributa

iative to encce prescriptioenate Bill 46

ng Program.ere will be a

will see lives

of Florida’s cities and comr Rick Scott

Bailey to heand Surgeon on in respon

ember 1, 20Online Repord substancectitioners be

ment agencieations on Nov

ease Controls arguably thNational Instof a medicatir feeling it caesponding to

al Drug Contrnforcement ACOS) data restate leading

drugs”.3 Flouse a top pri12-2015, Attwing and deaprehensively ed to the natble to a pres

courage the son drug dive62 into law o7 Senator Mreduction inbeing saved

comprehensimbat the crimappointed Fd the StatewGeneral Fra

nse to the on

11, Florida irting of Conte dispensing gan accessi

es began reqvember 14,

Int

l and Prevenhe epicenter titute on Druion without aauses.”2 In ho the Prescrrol Policy (OAdministratioeported nineg Florida to borida Attorneiority.4 Accotorney Geneadliest publicreact soone

tional public scription dru

safer prescrersion and abon June 18, 2Mike Fasanon doctor shod.”8

ive strategy minal distribFlorida Depawide Drug Stank Farmer ngoing probl

mplementedtrolled Substdata from p

ing the data questing PD2011.

roduction

ntion (CDC)of the presc

ug Abuse (NIa prescriptiois remarks t

ription Drug ONDCP), Exeon’s (DEA) Aety of the topbe known asey General Pording to Floral Bondi, stc safety issu

er to the exphealth crisisg overdose.

ribing of contbuse in the s2009, creati stated, “Onpping, reduc

to stop the fution of pres

artment of Latrike Force. issued a staem of presc

d its PDMP, tances and E

pharmacies areported to MP investig

classified prcription drugIDA) defines

on; in a way oto the SenatEpidemic, Gecutive OfficAutomation op 100 physics the nationaPam Bondi hrida’s Presctated, “Prescue.” In additplosion in pres.”5 In 2009,6

trolled subststate of Florng Florida’s ce the datab

ction in peop

flow of dangscription druaw Enforcem On July 1,

atewide publcription drug

known as EEvaluation)9

and dispensthe PDMP oative reports

rescription dg abuse epids prescriptioother than ae Caucus on

Gill Kerlikowsce of the Preof Reports acians purchaal epicenter fhas made th

cription Drugcription drugtion, “Floridaescription dr, one in eigh

tances and rrida, Governo

Prescriptionbase is up aple forging p

erous drugsugs in Floridament (FDLE)

2011, formeic health emabuse and d

E-FORCSE® 9 and began sing practitioon October 1s during the

drug abuse ademic in the n drug abus

as prescribedn Internationski, Director esident, stateand Consolidsing oxycodfor illicitly he fight again Diversion a

g abuse rema’s failure to ug diversion

ht deaths in

reduce contror Charlie Cn Drug nd running frescriptions

s into a, in March 2) Commissioer State Hea

mergency diversion in

(Electronic-receiving ners. Health17, 2011. Lacourse of ac

3 

 

as an

se as d; or nal of

ed, dated done

nst and ains

n and

rolled Crist

for a , and

2011, oner alth

h aw ctive

 

As of Ocestablishhave PD

Today, Pconsumehealth, aanalyze tpractitionnames adosage fpaymentthey diffe

W

tober 2013, hing a PDMPMPs that are

PDMPs are eer protectionnd boards otransmitted pners.12 The fend demograform of the d.13 Although

er in the follo

Contrsubstawhen substa

Levelconta

What Are Pr

forty-nine stP. Of those, e not yet ope

Status of P

established b, substance

of pharmacy.prescribing aederal and s

aphic informadrug, quantityh all PDMPsowing areas:

rolled substance prescriabused, andance.14

of authorizined in the P

rescription

tates, and twforty-seven

erational and

IlluPrescription

by state law abuse, law 11 PDMPs aand dispensstate controlation for the y dispensed collect and

tance schediptions based whether th

zed user acPDMP varies

n Drug Mon

wo United Ststates haved the Distric

ustration 1n Drug Mon

 

and are locaenforcemenacross the nsing data subled substancprescriber, , number of store contro

dules monitd on the rela

hey have a c

cess. The ls by state. S

nitoring Pr

tates Territoe operationact of Columb

nitoring Pro

ated in variont, professionnation collectbmitted by pce data colledispenser aauthorized

olled substan

tored. PDMative potenticurrently acc

level of acceSome states

rograms?

ries have enl PDMPs; twia has legisl

ograms

ous agenciesnal licensingt, store, monharmacies aected usuallynd patient, trefills, and thnce dispens

MPs monitor ial for abusecepted medic

ess to the infs allow direct

nacted legislwo other statation pendin

s such as g, departmennitor, and and dispensy includes ththe name anhe method oing informat

controlled e or dependecal use of th

formation t access to t

4 

 

ation tes, ng.10

nts of

ing he nd of tion,

ence he

the

 

History o 

The PDMcreated s

informpharmagencpatien

DispeSociedispenwidelyPDMPAct (Hprotec

TimelpharmmonthOklahsale ainformdispen

Type state users acceswhen

Interowidelywith aespecAlabastatesinformand co

MandvariesauthosettingFloridto pre

of Legislatio

MP was creasection 893.

mation maintamacists, whilecies under cents.15

enser reportty for Automnsing informy with respecPs must alsoHIPAA) as it cted health i

liness of damacies and dhly or bi-weehoma, requireand nine statmation to be nser dispens

of reports gPDMPs gensuch as pre

ss authority. there is reas

operability by with respecauthorized uscially in bordma law auth

s. However,mation into eoordination o

datory use os depending rity of practitg, patient’s ca does not r

escribing a co

on

ated by the 2055, F.S. A

ained in the e other stateertain circum

ting formatsmation in Phamation transm

ct to the speo comply witpertains to pnformation (

ata uploadeddispensers toekly, howevees dispensetes require duploaded tosing the pres

generated, serate solicite

escribers, dis Some stateson to suspe

between stact to whethesers in otherer states like

horizes acce Florida is alectronic heaof health info

of PDMPs. Son the schetioner to precourse of trerequire its heontrolled sub

Legal

2009 Florida A companion

PDMP dataes allow indimstances, lic

s. State PDarmacy (ASAmitted from tecific versionh Health Insprotected he(EPHI).16

d (reportedo report coner, most stateers to uploaddaily reportin the PDMP dscription.17

solicited reed reports inspensers, anes provide unect a patient

ates and other informationr states. Intee Florida, Al

ess by healthdopting techalth records ormation.19

State requireedule of the cescribe contreatment, andealth care prbstance.20

l Framewo

Legislature,bill, SB 440

abase to hearect access

censing boar

DMPs must bAP) for the vhe dispense

n of the standsurance Portealth informa

) to the PDMtrolled substes require w

d dispensingng. Florida rdatabase wi

eports versun response tnd other gronsolicited ret is doctor sh

her technoln contained eroperabilityabama, and

h care practihnology to into improve c

ements for mcontrolled surolled substad time intervaractitioners t

ork

, with the pa0, created se

alth care prato law enforrds, third pa

be consistenvalidation of er to the PDMdard in use.tability and Aation (PHI) a

MP. Some Ptance dispen

weekly uploa information

requires dispithin seven (

us unsolicitto a query byups with the

eports to authhopping.18

logy. State in the datab

y is extremeld Georgia. Otioners licen

ntegrate its Pcontinuity of

mandatory uubstance beances, practal between qto access the

assage of SBection 893.05

ctitioners anrcement rty payers, a

nt with Amerprescribing

MP. States Furthermo

Accountabilitand electroni

PDMPs requnsing inform

ading. One s at the time

pensing (7) days of th

ted reports.y authorized

e appropriatehorized user

PDMPs varybase is sharey important

Of the three, nsed in otherPDMP f care, safety

use of the PDeing prescribitioner’s pracquerying. e database

B 462, which551, F.S., w

5 

 

nd

and

ican and vary re, ty ic

uire mation state, of

he

. All d e rs

y ed

only r

y,

DMP bed, ctice

prior

h which

 

sets forthPDMP.  The 2010of SB 22managercontrolledinformati

The 2011Governodays of dPDMP; ato the PD

The 2013of HB 23optometrF.S. Witnonrecur2013-201

Summar

Section 8a compredispensincontrolledprofessio

The systePharmacindividuaAccountaprotected DOH muinformatiprovided care reguthe reporreportingother spe

The law ethat dispeestablish

A pharmapatient opatient’s

h the exemp

0 Florida Leg72, which esr to work withd substanceon to law en

1 Florida Legr’s Office of

dispensing raand to requirDMP.

3 Florida Leg9, which exp

rist who has h the passagrring genera14.

ry of Statute

893.055, F.Sehensive eleng informatiod substance

onal practice

em must be cy (ASAP) foal. The systeability Act (Hd health info

st adopt ruleon within theto pharmac

ulatory boardrting require

g requiremenecified stake

establishes enses a con

hes exemptio

acy, prescribf that pharmcontrolled d

tion from pu

gislature amstablished a h certain sta

e abuse. It anforcement u

gislature amDrug Contro

ather than 1re criminal ba

gislature ampands the dethe authorityge of HB115l revenue fu

e

S., creates thectronic dataon, while notes by a presce.

consistent wor the validatem must also

HIPAA) as it rmation (EP

es concernine system, in

cists and prads, law enfoments must

nts. DOH meholders to d

the type of introlled subsons from rep

ber, or dispemacy, prescridrug prescrip

ublic records

mended sectidefinition fo

akeholders toalso authorizunder certain

mended sectiol to DOH; to5 days; to prackground s

mended sectiefinition of hy to prescrib59, the 2013nds for the g

he PDMP wiabase systemt infringing ucriber or disp

with standartion of presco comply witpertains to p

PHI).

ng the reportcluding rulesctitioners anrcement, anbe notified bust work wit

develop indic

nformation ttance within

porting to the

enser may acber, or dispe

ption history.

requiremen

ons 893.055or “program mo promulgate

zed the progrn circumstan

on 893.055,o require reprohibit the us

screening for

ons 893.055ealth care p

be oral ocula3 Florida Leggeneral adm

thin DOH anm to collect cupon the legpenser actin

rds of the Amcribing and dth the Healthprotected he

ting, evaluats for when pnd rules for wnd others. Aby DOH of thh the profescators for co

that must ben seven (7) de PDMP.

ccess informenser for the. Prescriber

nts for inform

5 and 893.05manager,” ae rules settinram managences.

, F.S., to reaports be madse of certainr all PDMP s

5 and 893.05practitioner toar agents, pugislature app

ministration o

nd requires Dcontrolled suitimate pres

ng in good fa

merican Socdispensing ch Insurance

ealth informa

tion, managepatient adviswhen inform

All dispensershe implemen

ssional healtontrolled sub

e reported bydays of dispe

mation in thee purpose ofrs and dispe

mation conta

551, F.S., wand requires ng forth indicer to provide

assign the dude to the PDn funds to imstaff who ha

551, F.S., wo include a cursuant to sepropriated $5of the PDMP

DOH to desubstance precribing or dis

aith and in th

iety for Autoontrolled suPortability a

ation (PHI) a

ement, and ssory reports (ation is provs and prescrntation date h care licens

bstance abus

y a pharmacensing. In a

e PDMP thatf reviewing tnsers acting

ined in the

with the passthe program

cators of e relevant

uties of the DMP within 7mplement the

ve direct acc

with the passcertified ection 463.0500,000 of for fiscal ye

ign and estaescription spensing of

he course of

omation in bstances to

and nd electroni

storage of (PARs) are vided to hearibers subjecfor such

sure boards se.

cy or dispensaddition, the

t relates to aheir specific

g in good fait

6 

 

age m

7 e cess

age

0055,

ear

ablish

an

c

lth ct to

and

ser law

a c th for

 

receivingadministr Other acand exemThe folloregister t

• Dinsu

• Tsu

• Aa

• Aw

PerformaData thatinformatipublic he A practiticommits 775.083, All costs grant funLegislatu

DOH maboard of promotiodefined ato conduof moneyeither rearegistere 

Summar Section 8accessininformatilicensurerules app64K, Flor

g or using infrative liability

cess is limitempt informatwing entitiesto request in

DOH or appronvestigation ubstances;

The Attorney ubstances;

A law enforcectivity, fraud

A patient, legwritten reque

ance measut does not coon may be r

ealth care an

oner who wa misdemea F.S.

incurred by nding appliedure for fiscal

y establish adirectors apnal support

as a Florida ct programsy; acquire, real or persona

ed lobbyist.

ry of Admin

893.055, F.Sg, evaluatioon within the

e boards, propropriate for rida Adminis

formation froy.

ed to the protion in the das do not havformation fro

opriate healtinvolving a s

General for

ement agencd or theft relaal guardian st, for the pu

res are repoontain patienrequested dund safety init

illfully and knanor of the f

DOH to admd for or receiyear 2013-2

a direct-suppppointed by tfor the activnot-for-profit

s and activitieeceive, hold al; and make

nistrative Ru

S., directs DOn, manageme PDMP datofessional mimplementa

strative Code

om the progr

ogram’s manatabase is ove direct acceom the prog

th care reguspecific indiv

r Medicaid fr

cy during acating to presor designate

urpose of ve

orted annualnt, physicianuring the yeatiatives by ta

nowingly failfirst degree,

minister the ived by the s2014.

port organizathe State Suvities authorizt incorporatees; raise funand invest s

e expenditur

ules

OH to adoptment, develotabase. DOH

membership oation of the Pe, (F.A.C.), t

ram are imm

nager and denly releasedess to the inram manage

latory boardvidual for on

aud cases in

tive investigcribed contred health ca

erifying the in

ly by DOH en, health carar by DOH e

aking advant

ls to report tpunishable

PDMP muststate, excep

ation with a urgeon Genezed for the Ped under Chnds; request securities, fures in the fur

t rules as nepment, impleH collaboratorganization

PDMP. The to provide a

mune from an

esignated prd as providednformation iner or suppor

ds who are inne or more p

nvolving pre

ations regarrolled substaare surrogatenformation c

each Decemre practitioneemployees stage of obse

the dispensinas provided

t be funded tpt as authoriz

board of fiveeral, to providPDMP. A “dhapter 617, F

and receiveunds, objectsrtherance of

ecessary conementation,ted with stakns, and otherPDMP promframework f

ny civil, crim

rogram staffd in section n the databart staff:

nvolved in a rescribed co

escribed con

rding potentiances; or e who submcollected.

ber 1, beginer, or dispenso that DOH erved trends.

ng of controin sections

through fedezed by the 2

e or more mde assistanc

direct supporF.S., organize grants, giftss of value orf the program

ncerning rep operation, a

keholders, inr state agen

mulgated rulefor the admi

minal, or

f. Confident893.0551, Fse, but may

specific ontrolled

trolled

ial criminal

its a notarize

nning in 2011nser identifyi

may undert.

lled substan775.082 or

eral or privat2013 Florida

members, witce, funding, rt organizatiozed and opes and bequer other propem. It is not a

orting, and storage ncluding cies to devees in Chaptenistration of

7 

 

ial F.S.

ed

1. ng ake

nces

te

h a and on” is rated

ests erty a

of

elop er the

 

program.to and op

 Florida’s PDMP Foappropriasupport tmanufacdatabaseof the fun

• Taa

• FsbfoAP

• Tth$

DOH is cPDMP, afuture of

The Florisystem (health caprovidingfor PDMP2010 Ha0010) fun

 Section 8GovernoDecembe

. The promuperation of th

PDMP is fuoundation Bation by the the PDMP. turers may be infrastructunding source

The PDMP Fnd infrastrucre ongoing. ederal grantpecific projee used to of

our Harold RAbuse and MPDMP ElectroThe final souhe National A49,952. The

committed toand stands rethe program

Pre

ida PDMP imPDMS) durinare practitiong mapping caP staff to sharold Rogers nded these e

893.055(8), r, the Presider 1, beginn

ulgated ruleshe database

nded througBoard of Dire

legislature oFurther, no fbe used. Sinure and enhaes are as fol

oundation iscture, person ts are anothe

ects outlined ffset personn

Rogers PDMMental Health

onic Health rce of fundinAssociation

e grant period

o exploring oeady to work

m.

escription

mplemented ng October ners to updaapabilities foare reports ePrescription

enhancemen

F.S., requiredent of the Sing in 2011.

s set forth we, security of

Florida P

gh federal anectors. With of $500,000 funds receivnce its incepancements, lows:

s the primarynnel and fac

er source ofin the grant

nel and faciliP grants totah Services ARecord Inte

ng is private of State Cond ended Jun

other innovatk alongside

Drug Moni

several enh1, 2012 throte their own

or graphic reelectronicallyn Drug Monitnts.

Perform

es DOH to reSenate, and t

Based on

hat constitutf information

PDMP Fun

nd private grthe exceptiofor FY 2013

ved directly option in 2010personnel a

y source of rcility expense

f funds to opapplication

ity expensesaling $1,599

Administratiogration and grants. DO

ntrolled Subsne 30, 2011,

tive options various stak

itoring Sys

hancements ough Septem

contact infoepresentationy through thetoring Progra

ance Meas

eport its perfthe Speakerthese meas

tes advisoryn, and progra

nding

rant money aon of a one-t3-14, no stateor indirectly f0, the PDMPand facility ex

revenue to ces. The Fou

perate the PDand only a l

s. DOH appl9,250. DOH aon’s 2012 Co

InteroperabOH has receiv

stance Auth, and $44,88

for identifyinkeholders an

stem Enha

to its prescrmber 30, 201ormation andn of dispense database

ram Enhance

sures

formance mer of the Houssures, DOH h

y alerts and ram evaluatio

and funds ratime generae funds mayfrom prescri

P has spent $xpenses. A

cover databaundation’s fu

DMP. Awardlimited portioied for and walso receive

ooperative Aility Expansived three gr

horities (NAS86 was draw

ng and secund partners t

ancements

ription drug 3, including

d reset their sing history, with any PDement Grant

easures annse of Represhas provided

reports, acceon.

aised by the al revenue y be used to ption drug $1,519,297 f

A brief descri

ase operationundraising ef

ds are basedon (if any) mwas awarde

ed the SubstAgreement foion for $240rant awards SCSA) totalinwn down.

ring funds foto ensure the

monitoring the ability foown passwoand the abil

DMP user. Tt (2010-PM-

nually to the sentatives byd annual dat

8 

 

ess

for ption

n fforts

d on may

d ance

or ,105. from

ng

or the e

or ords, ity

The -BX-

y ta as

 

a basis o1, 2012 t

To assistmeasurethrough esubstanccoordinasafety an

1. Oth

 A. P

insy

During 20and dispeIncreaseincrease DATA TO

MEASUR

How mantrained fothe use o

How mantrained inmass maPDM syst

How manthere in y

What is tPRESCRone or mprescript

How mantrained fothe use o

How mantrained inmass maPDM syst

How manin your st

of comparativto Septembe

t in fulfilling ps related to education ances obtainedtion among

nd reduce pr

OUTCOME: hrough dep

PERFORMANndividuals auystem.

012-2013, Eensers, in and outreach ein registratio

O SUPPORT

RE FOR THIS

ny licensed Pormally (in a of the PDM sy

ny licensed Pnformally (e.gailings, and stem?

ny licensed Pyour state?21

he number oIBERS in youore controlletions.

ny licensed Dormally (in a of the PDM sy

ny licensed Dnformally (e.gailings, and stem? 

ny licensed Dtate?22

ve review froer 30, 2013.

program resits efforts tond safety effd by individuapartners andrescription d

Reduction partment ed

NCE MEASUuthorized to

E-FORCSE® n effort to inefforts, primaon and 61 p

T PERFORM

REPORTING

PRESCRIBERclassroom system?

PRESCRIBERg., via the Int

so on) in the

PRESCRIBER  

of licensed ur state that ed substance

DISPENSERSclassroom system?

DISPENSERSg., via the Int

so on) in the

DISPENSERS

om October

sponsibilities reduce the

forts; reduceals attemptind stakeholderug abuse a

of the rate ucation and

URE: The nuconduct inve

staff focusecrease regisarily in a formercent incre

MANCE MEA

G PERIOD

RS were setting) in

RS were ternet, use of the

RS are

issued e

S were setting) in

S were ternet, use of the

S are there

1, 2011 thro

s, DOH has irate of inapp

e the quantiting to engageers to achiev

and drug dive

of inappropd safety effo

umber of liceestigations t

ed its outreacstration and mal, classrooase in utiliza

ASURE

2011-20

1

ough Septem

dentified anpropriate usies of pharme in fraud anve improvedersion.

priate use oorts.

ensed presctrained in the

ch and educutilization ofom setting ration by pres

012

603

10,166

04,276

61,284

1,525

8,803

27,260

mber 30, 201

d is reportinse of prescripmaceutical cond deceit; an patient hea

of prescript

cribers, dispee use of the

cation effortsf the PDMP resulted in a scribers and

2012-2013

1,1

11,7

107,7

60,6

3,3

11,4

27,3

12 and Octo

g performanption drugs ontrolled nd to increasalth care and

ion drugs

ensers, and state’s PDM

s on prescribdatabase. 28 percent

d dispensers

% Cha

17 +8

705 +1

775 +

686

335 +11

418 +2

330 +

9 

 

ober

nce

se d

M

bers

.

ange

85.2%

15.1%

+3.4%

-1.0%

18.7%

29.7%

+0.3%

 

How manCONDUCformally (of the PD

How manCONDUCinformallmailings,system?

How manCONDUCyour stat

How manwww.e-fo

2. Oo

 A. P

p

Performaunique inindividuaperiod, thpercent) (+1.8 perhas beentable beloreceivingdosages

DATA TO

MEASURPERIOD

How manbeen repo

How manprescriptmorphinemg per dHow manprescriptmorphinemg per d

ny INDIVIDUACT INVESTIGA(in a classro

DM system?

ny INDIVIDUACT INVESTIGA

y (e.g., via th, and so on)

ny INDIVIDUACT INVESTIGA

e?23 

ny INDIVIDUAorcse.com?

OUTCOME: btained by

PERFORMANrescribed to

ance measundividuals reals to 6,662,4here has beeand sedativrcent) have in a 4.5 perceow summari

g prescriptionby therapeu

O SUPPORT

RE FOR THIS

ny prescriptioorted to the

ny adults rections for paine equivalent ay?

ny youth recetions for paine equivalent ay?

ALS AUTHORATIONS wer

oom setting)

ALS AUTHORATIONS wer

he Internet, min the use of

ALS AUTHORATIONS are

ALS visited w

Reduction oindividuals

NCE MEASUpatients in v

re data refleeceiving cont422 individuaen a decreases (-3.5 percincreased reent reductionizes the numns by schedutic class.

T PERFORM

REPORTING

on records hPDMP?

ceived nkillers with greater than

eived nkillers with greater than

RIZED TO re trained in the use

RIZED TO re trained mass f the PDM

RIZED TO there in

website-

of the quans.

URE: The nuvarious sche

ects there hatrolled substals when cose in the totacent) howevespectively fn in the total

mber of prescule, number

MANCE MEA

G

have

a n 100

a n 100

ntity of phar

umber of doedules.

as been a 0.2tances in schmpared to thal number of

ver, stimulanrom the prev number of dcriptions repr of patients

ASURE

2011-2012

34,108,8

3,2

1,530

3,207

49,888

36,226

rmaceutical

osage units o

2 percent dehedule II, III he previous f doses pres

nts (+10.1 pevious reportdoses by all

ported to theexceeding c

20

874

219

10

1

2,9

49,4

36,8

l controlled

of controlled

ecrease in thor IV from 6year. Durin

scribed for percent) and ting period. classes me

e PDMP, numcertain thres

012-2013

33,769,7

3,0

41 -9

953

418

864 +

substance

substances

he number o6,675,062 ng this reportpain relief (-7tranquilizersOverall, ther

easured. Thember of patieholds, and

% Cha

744

012

15 +5

10 

 

90.8%

-7.9%

-0.9%

+1.8%

s

s

of

ting 7.1 re e ents

ange

-0.9%

-6.4%

50.0%

 

How man

a. Sch

b. Sch

c. Sch

How man

a. Sch

Totb. Sch

Totc. Sche

How man

How man

a. 5 ormore dis

b. 10 omore dis

How manexceedin

a. 5 or

                  1 Some % c

ny patients fi

edule II

edule II and/

edule II, II an

ny doses wer

edule II Pain RelievStimulantsSedatives

al Schedule edule III

Pain RelievStimulantsSedatives

al Schedule edule IV

Pain RelievTranquilizeStimulantsSedatives Total Sche

ny doses werPain RelievTranquilizeStimulantsSedatives All Classes

ny patients e

r more prescpensers for s

or more prespensers for s

ny non-liquidg thresholds

r more presc

Pain RelievStimulantsSedatives All Scheduliquid dose

                       change calcula

lled prescrip

/or III

nd/or IV

re dispensed

vers s

II

vers s

III

vers ers s

edule IV re dispensedvers ers s

s

xceeded thre

ribers and 5 schedule II

cribers and schedule II

d doses of Scs?

ribers and 5

vers s

ule II (includies)                    tions are based

ptions for sc

d by schedul

d by therapeu

esholds?

or

10 or

chedule II pre

or more disp

ng

d on small cell 

heduled med

1,056,5

3,412,7

6,675,0

e during rep

548,597,5

70,115,512,0

618,725,0

406,581,5159,4

2,904,7409,645,7

997,9212,608,8

179,877,4393,484,2

utic class du956,177,0212,608,8

70,274,9182,794,2

1,421,855,0

9,1

2

escription dr

pensers

13,634,98 785,48 2

15,094,4

sizes which ca

dication duri

539

728

062

porting perio

553526013092

523417772712

973824

0 475272uring reportin049824943260076

31

210

rugs were di

84 88

26

444

an make rates 

ing the repor

1,082,9

3,460,4

6,662,4

d?1

479,852,077,248,3

9,4557,109,7

407,492,4142,2

2,530,9410,165,6

848,8216,434,3

173,838,5391,121,8

ng period? 888,193,3216,434,3

77,390,6176,378,9

1,358,397,2

6,1

1

ispensed to

7,294,3 532,4 1

8,402,2

unreliable. 

rting period?

977 +

485 +

422

016 -1352 +1407 -2775 -9

473 +225 -1937 -1635 +0

861 -1369 +30 +10

573 833 -0

350 369 +607 +1917 243

44 -3

49 -2

patients

374 -4427 -3

00 +28

277 -4

11 

 

?

+2.5%

+1.4%

-0.2%

12.5%10.2%21.7%9.96%

+0.2%10.8%12.9%0.13%

14.9%+1.8%00.0%-3.4%0.60%

-7.1%+1.8%10.1%-3.5%-4.5%

32.7%

29.0%

46.5%32.2%84.6%

44.3%

 

b. 10 o

How mana. 5 or

more disIII

b. 10 omore disIII

How manexceedin

a. 5 or

b. 10 o

How man

a. 5 ormore disand/or IV

b. 10 omore disand/or IV

How manpatients e

a. 5 or

b. 10 o

or more pres

Pain Reliev

StimulantsAll Scheduliquid dose

ny patients er more prescpensers for s

or more prespensers for s

ny non-liquidg thresholds

r more presc

Pain RelievStimulantsSedatives All Scheduliquid dose

or more pres

Pain RelievStimulantsSedatives

All Scheduliquid dose

ny patients e

r more prescpensers for s

V

or more prespensers for s

V

ny non-liquidexceeding th

r more presc

Pain RelievTranquilizeStimulantsSedatives All Scheduliquid dose

or more pres

Pain Reliev

cribers and

vers

s ule II (includies) xceeded threribers and 5 schedule II a

cribers and schedule II a

d doses of Scs?

ribers and 5

vers s

ule II (includies)

cribers and

vers s

ule II (includies)

xceeded thre

ribers and 5 schedule II, I

cribers and schedule II, I

d doses of Schresholds?

ribers and 5

vers ers s

ule II (includies)

cribers and

vers

10 or more d

ng

esholds? or

and/or

10 or and/or

chedule II an

or more disp

ng

10 or more d

ng

esholds?

or III

10 or III

chedule II, III

or more disp

ng

10 or more d

dispensers fo

357,8

28,7

406,8

23,73

90

nd/or III presc

pensers

31,370,5 1,706,3 59,7

36,396,4

dispensers

1,447,0 73,7 1,7

1,680,2

37,7

1,4

and/or IV pr

pensers

44,792,3 5,320,2 2,164,2 3,186,9

73,407,6

dispensers

2,200,7

or schedule

845

741

838

36

04

cription drug

544392 791

448

022 735 773

286

750

482

rescription d

394202 251 977

692

752

II

202,4

17,1

248,5

18,3

6

gs were disp

19,904,6 1,370,5 47,9

24,327,1

804,0 49,1 3

1,006,0

30,6

9

drugs were d

30,177,5 4,458,1 1,816,8 2,537,8

52,764,0

1,161,6

490 -4

07 -4

550 -3

361 -2

601 -3

ensed to pat

699 -3577 -1935 -1

65 -3

038 -496 -3

324 -8

010 -4

699 -1

948 -3

dispensed to

541 -336 -1

891 -1872 -2

089 -2

693 -4

12 

 

43.4%

40.5%

38.9%

22.6%

33.5%

tients

36.5%19.7%19.8%

33.2%

44.4%33.3%81.7%

40.1%

18.7%

36.0%

32.6%16.2%16.0%20.4%

28.1%

47.2%

 

B. Pp

The Drugan 18 peprescript41 percebelow su

DATA TO

MEASUR

How macontrolleprimary How maoxycodocontribu

C. P

p In 2013, five drugdispenseprescript32,010,7number o Hydrocoddispensedispense86,188 le2012.

For two oquantitiesincrease percent) table proprescriptchange.

TranquilizeStimulantsSedatives All Scheduliquid dose

PERFORMANrescription d

gs Identified ercent decreaions was ide

ent and overaummarizes th

O SUPPORT

RE FOR THIS

ny coroner ed prescripor contribuny coroner

one was theuting cause

PERFORMANrescriptions

dispensers s listed in th

ed during thision records 53 prescriptof prescriptio

done with aced controlleded, followed ess hydrocod

of the four ms fell 23.79 pin the numband testoste

ovides a sumions dispens

ers s

ule II (includies)

NCE MEASUdrug use as t

in Deceasease in the nuentified as thall drug deathis significan

T PERFORM

REPORTING

reports indtion drug u

uting cause reports ind

e primary orof death?

NCE MEASUof the most

reported 33,e table belos reporting preported to ttions reporteons dispense

cetaminophed substance,by alprazoladone and ac

most harmful2

percent and ber of hydrocerone cypion

mmary of the sed during 2

ng

URE: The nuthe primary

ed Persons bumber of deahe primary caths fell by 9.nt change.

MANCE MEA

G PERIOD

dicated thatse was the of death?

dicated r

URE: Numbcommonly d

,769,744 prew represent

period. Whethe PDMP a

ed. Overall, ed during th

en ranks num representin

am and zolpicetaminophe

25 prescriptio7.78 percen

codone/homnate (+26.35top twenty-f

2011-2012 a

301,6 102,5 206,6

3,703,5

umber of coor contributi

by Florida Meaths in whicause of deat9 percent w

ASURE

1/1/11-

t

ber of prescrdispensed co

escriptions rets 94.04 percen comparedand the top twthere has beis reporting

mber one asng 18 percenidem. Thereen prescriptio

on drugs, oxnt respective

matropine (+15 percent) prfive total numnd 2012-201

627 579 640

516

roner reporting cause of

edical Examh one or moth, while oxyhen compar

12/31/11 1

2,539

1,247

riptions and ontrolled su

ecords to thcent or 31,6d to 2012, thwenty-five reeen a 0.010period for th

s the most cont of all contre has been aons dispens

xycodone anely. There h12.83 percenrescriptions mber of cont13 reporting

187,2 67,4 111,0

2,041,4

ts that indicaf death.

miners 2012 ore controlledycodone deared with 201

1/1/12-12/31/

2,0

7

percentage bstances.

e PDMP and80,618 pres

here were 34epresented 93 percent re

he top twenty

ommonly prerolled substaa 1.42 percesed when co

nd methadonas been a snt), hydromodispensed. trolled subst periods and

243 -3487 -3041 -4

406 -4

ate controlled

Report24 shod substanceaths plunged1. The table

/12 % Cha

090 -1

735 -4

of total

d the top twescriptions 4,108,874 94.31 perce

eduction in thy-five drugs.

escribed andances ent reductionmpared to 2

ne, prescriptiignificant

orphone (+17The followin

tance d the percen

13 

 

37.9%34.2%46.3%

44.9%

d

ows e d by e

ange

17.7%

41.0%

enty-

ent or he .

d

n or 2011-

ion

7.73 ng

nt

 

DATA TO

RANK

1 H

2 A

3 Z

4 O

5 O

6 C

7 L

8 T

9 DA

10 D

11 P

12 M

13 C

14 M

15 A

16 T

17 L

18 B

19 H

20 M

21 F

22 E

23 H

24 T

25 D

T

 D. P

o

In 2012, 2013, 60change iOverall, t34,108,8

O SUPPORT

CONTROLDI

Hydrocodone

Alprazolam

Zolpidem

Oxycodone /

Oxycodone H

Clonazepam

Lorazepam

Temazepam

DextroampheAmphetamin

Diazepam

Phentermine

Morphine Su

Carisoprodo

Methylphenid

Acetaminoph

Testosterone

Lisdexamfeta

Buprenorphi

Hydromorph

Methadone

Fentanyl

Eszopiclone

Hydrocodone

Testosterone

Dexmethylph

OTAL

PERFORMANut-of-state p

60,577 in-st,686 in-staten the total nthere was a 74 to 33,769

T PERFORM

LLED SUBSTISPENSED

e / Acetamin

/ Acetaminop

HCL

etamine / ne

e

ulfate

l

date

hen with Cod

e

amine Dimes

ne / Naloxon

one

e / Homatrop

e Cypionate

henidate

NCE MEASUprescribers d

tate prescribe prescribersumber of co0.9 percent 9,744 by in-s

MANCE MEA

TANCE

nophen

phen

deine

slyate

ne

pine

3

URE: Percedispensed by

bers issued 3s issued 32,ntrolled subreduction in

state and ou

ASURE

2011-201

RX QTY

6,067,076

4,409,770

3,013,853

2,647,691

1,822,164

1,815,594

1,701,866

1,405,402

1,023,127

1,022,484

889,466

849,242

734,121

606,351

543,952

525,667

481,320

438,425

399,251

393,207

349,642

239,541

234,697

220,062

176,782

32,010,753

entage of toty pharmacie

32,803,366 c728,597 prestance pres

n the total nuut-of-state pr

12

% RX R

17.88% 5

12.99% 4

8.88% 2

7.80% 2

5.37% 1

5.35% 1

5.01% 1

4.14% 1

3.01% 1

3.01%

2.62%

2.50%

2.16%

1.79%

1.60%

1.55%

1.42%

1.29%

1.18%

1.16%

1.03%

0.71%

0.69%

0.65%

0.52%

94.31% 31

tal prescriptis registered

controlled suescriptions, rcriptions iss

umber of prerescribers di

2012-2013

RX QTY %

,980,888 17

,299,247 12

,853,680 8

,651,480 7

,388,650 4

,903,217 5

,711,515 5

,421,186 4

,144,500 3

994,177 2

955,556 2

934,630 2

612,001 1

588,885 1

520,426 1

571,637 1

536,971 1

479,437 1

470,022 1

362,627 1

370,070 1

209,563 0

264,810 0

278,056 0

177,387 0

,680,618 94

ons written d in Florida.

ubstance prerepresentingsued by in-stescriptions wspensed in

3 %

Cha

% RX RX

7.75% -1

2.76% -2

8.47% -5

7.87% +0

4.12% -23

5.65% +4

5.08% +0

4.22% +1

3.40% +11

2.95% -2

2.84% +7

2.77% +10

1.82% -16

1.75% -2

1.54% -4

1.70% +8

1.59% +11

1.42% +9

1.39% +17

1.08% -7

1.10% +5

0.62% -12

0.79% +12

0.83% +26

0.53% +0

4.04% -0.0

by in-state a

escriptions. g a 0.2 percetate prescrib

written from Florida.

14 

 

% ange

QTY

1.42%

2.51%

5.31%

0.14%

3.79%

4.83%

0.57%

1.12%

1.86%

2.77%

7.43%

0.05%

6.63%

2.88%

4.33%

8.75%

1.56%

9.35%

7.73%

7.78%

5.84%

2.51%

2.83%

6.35%

0.34%

103%

and

In ent bers.

 

DATA TO

MEASUR

Number oprescribeNumber ostate pres

Total Pre

 E. P

x

Rule 64Kobtains aa 90-day

During thFORCSEprescribea 90-day2013), thprescribesummary

DATA TO

Individuaand X Nu

5 or more

6 or more

7 or more

8 or more

9 or more

10 or mopharmac

15 or mopharmac

 

3. Op

 

A. Pp

DispenseThere ha

O SUPPORT

RE FOR THIS

of prescriptioers dispenseof prescriptioscribers disp

escriptions

PERFORMANnumber of d

K-1.007, F.Aa prescriptiony period.

he first quartE® data indiced to them by period. By here was a 5ers and morey of the sign

O SUPPORT

als Visiting Xumber Dispen

e prescribers

e prescribers

e prescribers

e prescribers

e prescribers

re prescribeies

re prescribeies

OUTCOME: rescription

PERFORMANrescription d

ers are requas been an in

T PERFORM

REPORTING

ons written bed in Florida ons written bpensed in Flo

NCE MEASUdispensers in

A.C., identifien for a contr

er of E-FORcated there wby more than

the end of t51 percent ree than five pificant result

T PERFORM

X Number of nsers within

s & 5 or more

s & 6 or more

s & 7 or more

s & 8 or more

s & 9 or more

rs & 10 or m

rs & 15 or m

Increased cdrug monit

NCE MEASUdata.

ired to reporncrease in th

MANCE MEA

G PERIOD

by in-state

by out-of-orida

URE: Numbn a 90 day p

es the indicatrolled substa

RCSE®’s opewere 2,864 in five prescrihe fourth qu

eduction or 1pharmacies wts.

MANCE MEA

Prescribers 90-day perio

e pharmacie

e pharmacie

e pharmacie

e pharmacie

e pharmacie

ore

ore

coordinationtoring prog

URE: Numb

rt dispensinghe number o

ASURE

2011-2

32,80

1,30

34,10

er of individperiod.

tors for contance from m

eration (Octondividuals wbers and dis

uarter of 2011,441 less inwithin a 90-d

ASURE

od Q1 201

s

s

s

s

s

n among pagram.

ber of unique

g data to theof pharmacie

2012 2

03,366

05,508

08,874

uals visiting

trolled substaultiple presc

ober 1, 2011who had onespensed at m2-2013 (July

ndividuals visday period.

11-2012 Q

2,864

1,097

514

295

172

105

18

artners part

e dispensers

e PDMP withes and dispe

2012-2013

32,728,59

1,041,14

33,769,74

x number o

ance abuse cribers and d

to Decembe or more premore than fivy 1, 2013 to siting more tThe table be

Q4 2012-2013

1,415

427

178

86

5

3

7

ticipating in

s that have r

hin 7 days ofensing practi

% Chan

7 -

7 -2

4

of prescribers

as a patientdispensers w

er 31, 2011)escription drve pharmacSeptember

than five elow provide

3 % Chan

5 -5

7 -6

8 -6

6 -7

1 -7

1 -7

7 -6

n the

reported

f dispensingitioners repo

15 

 

nge

0.2%

20.2%

-0.9%

s and

t who within

), E-rugs ies in 30,

es a

nge

50.6%

61.1%

65.4%

70.8%

70.3%

70.5%

61.1%

. orting

16

controlled substance dispensing information to the database from 5,488 in 2011-2012 to 6,071 in 2012-2013. This represents a 10.6 percent increase in the number of pharmacies and dispensing practitioners reporting controlled substance dispensing information to the PDMP.

DATA TO SUPPORT PERFORMANCE MEASURE

MEASURE FOR THIS REPORTING PERIOD 2011-2012 2012-2013 % Change

Number of Pharmacies/Dispensers that have reported to the PDMP

5,488 6,071 +10.6%

B. PERFORMANCE MEASURE: The number of authorized users who have requested and

received controlled substance dispensing information by user type.

Health care practitioner registration increased 28 percent, from 18,059 to 23,084, and utilization increased 61 percent from 2,342,486 to 3,793,370, when compared to 2011-2012.

Among all licensed health care practitioners, pharmacists have the highest registration rate, 40.5 percent. Among all prescribers, osteopathic physicians have the highest registration rate, 24.3 percent. Overall, 16.4 percent of all licensed health care practitioners, as defined in section 893.055(1)(d), F.S., have registered to use the database.

In addition, pharmacists have the highest utilization rate, 89.2 percent, and have queried the database 3,625,519 times. Furthermore, 70.8 percent of all prescribers registered to use the database have queried 2,859,105 times. In particular, physician assistants have the highest utilization rate, 78.8 percent among all prescribers, and have queried the database 160,823 times. Overall, 80 percent or 23,084 health care practitioners who have registered to use the database have queried the database 6,484,624 times.

Certain law enforcement and investigative agencies may request controlled substance prescription information from the program manager during the course of an active investigation related to prescribed controlled substances. Since implementation, 152 law enforcement and investigative agencies appointed 915 registered users, of whom 498 submitted 33,173 requests for information.

The tables below provide a summary of results by user type as of October 31, 2013.

DATA TO SUPPORT PERFORMANCE MEASURE

User Type Total

Registered Users

Total Requests by User Type

% Registered Users that have made Requests

Total # Licensed

HCP

% Licensed Practitioners Registered

Health Care Practitioners (HCP)

Advanced Registered Nurse Practitioners

1,043 155,465 71.10% 17,843 5.9%

Dentists 553 7,006 55.00% 12,818 4.3%

17

Medical Doctors 7,305 2,087,225 69.70% 66,385 11.0%

Osteopathic Physicians

1,499 447,267 77.70% 6,175 24.3%

Physician Assistants

943 160,823 78.80% 6,628 14.2%

Podiatric Physicians

88 1,319 50.00% 1,845 4.8%

Sub-Total 11,431 2,859,105 70.80% 111,694 10.2%

Pharmacists 11,653 3,625,519 89.20% 28,749 40.5%

TOTAL HCP 23,084 6,484,624 80.00% 140,443 16.4%

Law Enforcement Users Total

Requests

Regulatory Board 6 224

Medicaid Fraud Unit

5 110

Law Enforcement 487 32,839

Total Law Enforcement

498 33,173

C. PERFORMANCE MEASURE: Number of individuals receiving controlled substances prescriptions and number of controlled substances dispensed by Florida counties.

There has been an overall reduction of 0.46 percent or 29,021 fewer individuals receiving controlled substances and an overall decrease of 0.85 percent or 284,345 less prescriptions dispensed to individuals in Florida counties. The data in this table does not take into consideration controlled substance prescriptions reported for individuals located in counties outside of Florida.

DATA TO SUPPORT PERFORMANCE MEASURE

COUNTY 2011-2012 2012-2013 % Change

Individuals RX Count Individuals Rx Count Individuals Rx Count

Alachua 73,882 352,064 73,677 352,753 -0.28% +0.20%

Baker 10,739 71,772 11,002 71,382 +2.45% -0.54%

Bay 76,182 437,855 75,079 446,420 -1.45% +1.96%

Bradford 10,003 65,493 10,214 63,044 +2.11% -3.74%

Brevard 214,241 1,195,741 210,566 1,204,531 -1.72% +0.74%

 

Broward

Calhoun

Charlotte

Citrus

Clay

Collier

Columbia

Desoto

Dixie

Duval

Escambia

Flagler

Franklin

Gadsden

Gilchrist

Glades

Gulf

Hamilton

Hardee

Hendry

Hernando

Highland

Hillsboro

Holmes

Indian Ri

Jackson

Jefferson

Lafayette

Lake

e

a

a

o

s

ough

ver

n

e

513,964

4,748

58,915

58,007

74,602

105,102

23,361

8,264

5,167

327,105

117,872

36,016

4,211

14,285

5,881

2,782

5,843

3,638

6,478

9,511

64,952

32,407

405,545

6,756

50,901

18,713

4,654

2,317

107,590

2,574,979

28,023

328,990

347,087

445,583

492,139

144,806

44,478

33,402

1,773,607

679,003

195,680

28,535

60,645

35,818

15,100

32,921

26,719

29,179

48,387

408,373

157,077

2,132,569

46,285

278,894

103,071

33,496

12,741

531,666

9 514,343

3 4,596

0 58,970

7 59,076

3 74,238

9 102,136

6 23,913

8 8,260

2 5,080

7 325,517

3 117,543

0 35,970

5 4,103

5 14,321

8 6,008

0 2,783

5,716

9 3,687

9 6,650

7 9,932

3 65,765

7 32,146

9 400,421

5 6,613

4 50,953

18,129

6 4,562

2,212

6 107,443

3 2,486,6

6 29,2

0 322,1

6 339,0

8 444,6

6 506,6

3 146,5

0 44,6

0 32,1

7 1,770,9

3 672,1

0 201,1

3 27,5

1 60,8

8 34,3

3 15,5

6 34,2

7 25,7

0 29,3

2 46,4

5 399,8

6 158,9

1 2,134,2

3 47,8

3 262,9

9 107,9

2 31,8

2 14,2

3 526,9

27 +0

62 -3

98 +0

35 +1

85 -0

72 -2

592 +2

69 -0

06 -1

71 -0

99 -0

06 -0

65 -2

05 +0

27 +2

31 +0

81 -2

26 +1

35 +2

09 +4

81 +1

90 -0

86 -1

05 -2

70 +0

53 -3

48 -1

17 -4

05 -0

.07% -3

3.20% +4

.09% -2

.84% -2

.49% -0

.82% +2

.36% +1

.05% +0

.68% -3

.49% -0

.28% -1

.13% +2

.56% -3

.25% +0

.16% -4

.04% +2

.17% +4

.35% -3

.66% +0

.43% -4

.25% -2

.81% +1

.26% +0

.12% +3

.10% -5

3.12% +4

.98% -4

.53% +11

.14% -0

18 

 

3.43%

4.42%

2.06%

2.32%

0.20%

2.95%

1.23%

0.43%

3.88%

0.15%

1.00%

2.77%

3.40%

0.26%

4.16%

2.85%

4.13%

3.72%

0.53%

4.09%

2.08%

1.22%

0.08%

3.28%

5.71%

4.74%

4.92%

1.58%

0.90%

 

Lee

Leon

Levy

Liberty

Madison

Manatee

Marion

Martin

Miami-Da

Monroe

Nassau

Okaloosa

Okeecho

Orange

Osceola

Palm Bea

Pasco

Pinellas

Polk

Putnam

Santa Ro

Sarasota

Seminole

St. Johns

St. Lucie

Sumter

Suwanne

Taylor

Union

ade

a

bee

ach

osa

e

s

ee

207,691

86,016

14,508

2,403

4,772

116,666

115,948

50,595

657,204

28,170

32,057

68,031

13,102

329,059

83,282

444,164

175,504

340,464

200,781

29,045

61,372

140,812

138,964

76,486

87,866

37,035

14,457

9,155

4,403

1,079,518

400,388

86,413

14,574

30,762

652,891

646,168

270,040

3,120,129

163,250

209,887

366,535

76,791

1,506,334

364,310

2,336,220

1,078,497

2,093,061

1,002,049

187,045

361,005

789,659

715,955

396,508

475,478

157,723

85,919

55,527

28,504

8 208,270

8 86,480

3 14,694

4 2,397

2 4,881

116,012

8 118,686

0 50,054

9 645,174

0 28,807

7 32,254

5 67,225

13,450

4 323,750

0 80,888

0 440,876

7 177,027

342,593

9 202,543

5 29,703

5 60,544

9 141,189

5 138,363

8 74,339

8 88,401

3 35,672

9 14,876

7 9,394

4 4,307

0 1,069,5

0 408,2

4 82,6

7 14,2

1 30,3

2 655,0

6 628,5

4 264,3

4 3,138,2

7 149,0

4 210,9

5 374,1

0 76,7

0 1,493,5

8 368,3

6 2,296,0

7 1,060,8

3 2,040,8

3 984,8

3 182,8

4 361,5

9 783,7

3 709,2

9 401,4

1 457,8

2 160,9

6 84,2

4 55,2

7 28,9

584 +0

33 +0

81 +1

90 -0

08 +2

39 -0

577 +2

51 -1

97 -1

35 +2

35 +0

65 -1

75 +2

519 -1

40 -2

01 -0

52 +0

97 +0

34 +0

63 +2

542 -1

71 +0

73 -0

32 -2

25 +0

82 -3

92 +2

62 +2

50 -2

.28% -0

.54% +1

.28% -4

.25% -1

.28% -1

.56% +0

.36% -2

.07% -2

.83% +0

.26% -8

.61% +0

.18% +2

.66% -0

.61% -0

.87% +1

.74% -1

.87% -1

.63% -2

.88% -1

.27% -2

.35% +0

.27% -0

.43% -0

.81% +1

.61% -3

3.68% +2

.90% -1

.61% -0

.18% +1

19 

 

0.92%

1.96%

4.32%

1.95%

1.48%

0.33%

2.72%

2.11%

0.58%

8.71%

0.50%

2.08%

0.02%

0.85%

1.11%

1.72%

1.64%

2.49%

1.72%

2.24%

0.15%

0.75%

0.93%

1.24%

3.71%

2.07%

1.89%

0.48%

1.56%

 

Volusia

Wakulla

Walton

Washingt

TOTAL

4. Oad

 

A. Pad

There haengagedat meetin

DATA TO

MEASUR

How manthrough mmeeting a

 PDMP efconcert wBrandeisassessmimpact isabuse, amaximizeappropriain ways adomains safeguar

Best pracsystems,electronicdata are prescribi

ton

OUTCOME: nd safety aiversion.

PERFORMANgencies; prorug abuse a

as been a sig in the PDM

ngs. The tab

O SUPPORT

RE FOR THIS

ny stakeholdmemorandumattendance,

ffectiveness with other ags University,

ment of the evs ensuring apnd improvinged when theately and exand formats by all appro

rd public hea

ctices includ, including pc prescribingseamlessly ng and addr

183,657

11,523

24,103

9,525

6,263,454

Involvemennd reductio

NCE MEASUofessional asand diversion

gnificant incrP implemenble below pr

T PERFORM

REPORTING

ers engagedms of undersetc.?

Eff

can also begencies, orgaPrescriptionvidence for bppropriate ug health out

e patient’s prpeditiously; that best se

opriate usersalth and redu

de data standublic health,g, public safavailable to

ressing the p

1,108,304

64,338

137,389

72,361

33,325,710

nt of stakehon of prescr

URE: Percessociations, n.

rease, 927 pntation througovides a sum

MANCE MEA

G PERIOD

d in the projestanding,

fectiveness

e understoodanizations an Drug Monitbest practicese of prescrcomes, both

rescription hmade availa

erve the purps.”26 PDMPsuce prescrip

dardization a health infor

fety, drug aball those en

prescription d

4 186,066

8 11,580

9 22,902

9,412

0 6,234,433

olders in acription drug

ntage of staetc.) involve

percent, in thgh memoranmmary of the

ASURE

2011

ect

s of Florid

d in the contend health intoring Prograes: “The effeription controh at the patieistory is comable in a proposes of ends may be ontion drug ab

and sharing rmation exch

buse preventngaged in imdrug abuse

6 1,093,0

0 65,4

2 142,8

2 74,0

3 33,041,3

chieving img abuse and

keholder (e.ement in the

he number ondums of une significant

-2012 2

51

a’s PDMP

ext of how Pformation team Center o

ectiveness oolled substanent and commplete and aoactive and td users; and e of the mos

buse and div

among agehanges, election and drug

mproving conepidemic.

78 +1

03 +0

12 -4

81 -1

65 -0

mproved patd prescriptio

.g., state, fed reduction o

of stakeholdenderstandingt results.

2012-2013

524

PDMPs workechnologies.of Excellenceof the PDMP nces, reducimunity level

accurate; anaimely manneapplied in a

st effective tversion.27

ncies, integrctronic healtg control. T

ntrolled subs

.31% -1

.49% +1

.98% +3

.19% +2

.46% -0

tient health on drug

deral, and loof prescriptio

ers that haveg and attend

% Chan

+

k best and in According e, in its in terms of

ing diversionls. Impact isalyzed er; disseminall relevant ools utilized

ration with oh records, his will ensu

stance

20 

 

1.37%

1.66%

3.95%

2.38%

0.85%

care

ocal on

e ance

nge

927%

n to

n and s

nated

to

other

ure

 

The effecand in th

Reducin 

Thirty-fousubstancdispensindispensinprescribenumber oproactive

During thFORCSEto them bperiod. Bdata revepharmac

Furthermthan six pof the foureductionpharmacpractitiona summawithin a 9

The Nu

ctiveness of e results of a

ng Doctor S

ur states, incce dispensinng thresholdng data, PDMers from whoof pharmacieely report this

he first quartE® data reveby more thanBy the end oealed 1,415 cies within a

more, 1,097 iprescribers aurth quarter n or 670 fewcies within a ner use of E-ary of significa90-day period

mber of Uni

Florida’s PDa user surve

hopping

cluding Florig informatio

ds are reacheMPs identifyom a patientes that haves information

er of E-FORaled 2,864 in five prescrof the fourth individuals v90-day perio

ndividuals hand dispensof 2012-201er individual90-day perio-FORCSE® iant results fod.

ique Patient

DMP is reflecey conducted

da, authorizn directly to ed.28 Throu

y potential dot has obtainee dispensed n to the pres

RCSE®’s opendividuals wribers and diquarter of 20visiting moreod, a 51 per

had one or msed at more t3 (July 1, 20ls visiting mood. The datincreases, dor those indiv

ts Identified

cted in a sigd during the

e the provisprescribers gh its monitooctor shoppeed a controllthe prescripscribing phys

eration (Octowho had onespensed at 012-2013 (J

e than five prrcent reductio

more prescripthan six pha013 to Septeore than six a supports toctor shopp

viduals visitin

by Thresho

gnificant decreporting pe

ion of unsoliwhen certa

oring and aners using a ted substanc

ptions, duringsician.29

ober 1, 2011e or more premore than fi

July 1, 2013 rescribers aon.

ption drugs parmacies in aember 30, 20prescribers

that as regisping decreasng multiple pr

old Levels 5

rease in doceriod.

icited reportsin prescribinnalysis of prethreshold of ce prescriptiog a specified

to Decembescription drive pharmacto Septembnd more tha

prescribed toa 90-day per013), there wand more th

stration and hses. The graprescribers an

& 6 by Quar

ctor shoppin

s of controlleng and escribing anthe numberon and the

d period and

er 31, 2011)rugs prescribcies in a 90-der 30, 2013)

an five

o them by mriod. By thewas a 61 pehan six health care ph below prond pharmacie

rter (2012-20

21 

 

g

ed

nd r of

), E-bed day ), the

more e end ercent

ovides es

013)

 

Similar represcribeprovides multiple p

The Num

PDMP S In additioDOH senE-FORCeffectivenwere askdon’t knoFlorida licthe 1,6102,000 noregistere

Of those respondeshoppingthe surveprovide a

eductions weers dispensea summary o

pharmacies w

mber of Uniq

urvey

on to measunt an electroSE® users inness of E-FOked to rate itsow, no respocensed heal0 valid respo

on-users of thed users of th

that have exents indicateg” by patientsey results is a summary o

ere observeed by 15 or mof significant within a 90-da

que Patients

ring the redunic survey ton March 201ORCSE® as s effectivene

onse.31 “DOlth care praconses receivhe PDMP (2he PDMP (5

xperience wed it was vers seeking toavailable on

of three ques

d for individumore pharmaresults for th

ay period.

s Identified b

uction in doco 2,000 regis3.30 The sura tool to red

ess using a sH received 1ctitioners, resved to the su28 percent) a2 percent).”3

with E-FORCry useful or so access or an the PDMP stions asked

uals receivinacies duringhose individu

by Threshol

ctor shoppingstered E-FOrvey was useduce doctor scale: very 1,610 responsulting in an

urvey, 564 reand 1,046 we32

SE®, the vassomewhat usabuse controwebsite at w

d in the PDM

ng prescriptig a 90-day peuals visiting m

d Levels 7 t

g trends to dORCSE® useed to assessshopping anuseful, somnses of the s

n overall respesponses weere from the

st majority (8seful in helpolled substanwww.eforcse

MP Survey.

ons from uperiod. The g

multiple presc

to 15 by Qua

demonstrateers and 2,00s the perceivnd health ca

mewhat usefusample grouponse rate oere from the e sample gro

86.4 percenping to contronces.33 A coe.com. The t

p to 15 or mograph below cribers and

arter (2012-2

e effectivene0 non-registved re practition

ul, not usefulup of 4,000 of 40 percen

sample grooup of 2,000

t) of the ol “doctor omplete coptables follow

22 

 

ore

2013)

ess, tered

ners l,

t. Of up of

py of wing

 

Questio

  To assesand dispeprescribecontrolledthat haveshould be

Questio

 

 DOH alsoof using in the lasof using percent);providerspercent).

Questiothe

n: In your exshopping

Rating

Very useful

Somewhat u

Not useful

Don’t know

No Respons

ss the perceensing decisers and disped substancee experiencee used.35 Th

on: Should al

Rating

Yes

No

Don’t Know

No Response

o asked the E-FORCSE®

st 30 days.36

E-FORCSE®

; (2) confirms or pharmac.37 The table

on: In the pase PDMS to mo

xperience, hog” by patient

useful

se

ived effectivsions, the PDensers shou

es using the e with E-FORhe table belo

l prescribersr

e

respondent® to monitor The top fou

® are: (1) sping a patientcies (14 perce below prov

st 30 days, wonitor contro

ow useful hats seeking to

veness of E-FDMP asked uld use E-FOfollowing sc

RCSE®, the ow provides

s and dispenrelated to co

s which actiocontrolled s

ur actions taeaking with t is not misucent); and (4vides a summ

which of the folled substan

as the PDMP o access or a

Tota

FORCSE® ahealth care

ORCSE® to iale: yes, no,vast majoritya summary

nsers use thentrolled subs

Tota

on the healtsubstance praken by respa patient absing prescri

4) confirmingmary of sign

following actnce prescrip

been so far abuse contro

Freque

al

as a clinical tpractitionersnform their c, don’t knowy (83 percen

y of the signif

e PDMP to instances?

Freque

al

h care practrescription mpondents in tbout his/her cptions (19 pg that a patienificant resul

tions have yoption medica

in helping toolled substan

ency P

688

215

26

43

74

1046

tool to help gs to rate wheclinical decis

w, no responsnt) believe Eficant results

nform their c

ency P

866

50

46

84

1046

titioner had tmedications fthe last 30 dcontrolled su

percent); (3) ent is “doctots.

ou taken as tions for you

o control “donces?

ercent

65.8%

20.6%

2.5%

4.1%

7.1%

100.0%

guide prescrether all sions relatedse.34 Of tho

E-FORCSE®

s.

linical decis

Percent

82.8%

4.8%

4.4%

8.0%

100.0%

taken as a refor their patiays as a resubstance uscontacting o

or shopping”

a result of usur patients?

23 

 

octor

ribing

d to se

ions

esult ents, sult e (20

other (14

sing

 

Rating

Establis

Reduc

Ref

*Note: Thmore than

 As the agpositionepublic heand phar(2) identioptions; adoctor sh

Florida hE-FORCReport, acontrolledshopping

The impafound whthrough Sbeen 33,indicatingprevious reported doses. S

Spoken w

shed a contro

ced or elimina

Changed c

Referr

ferred or reco

he total frequen one choice.

gency charged to operateealth – prescrmacists fromfy potential aand (3) idenhoppers and

as seen proSE®, the Druand recent Dd substance

g and reduci

act of E-FORhen compariSeptember 3769,744 preg each uniqureporting pefor all thera

Specifically,

with a patient a

Co

Confirm

Colled substanc

ated controlle

controlled sub

ed or recomm

Referred o

ommended for

ency is more

ed with prote E-FORCSEcription drug m becoming abusers to htify diversion over-prescr

omising resuugs Identifie

DOH survey es and addreng the death

RCSE® as a ng the result30, 2013 to Oescriptions reue patient averiod. Therepeutic classthere has be

about his/her

ontacted other

med patient n

Confirmed patce agreement

ed substance

bstance prescsubstance

Dismis

mended for su

or recommend

r anxiety (or o

Re

Re

than the num

Co

tecting the pE®, a criticalabuse and dunwitting ac

help medicaln trends as tribers.38

lts since theed in Deceasresults sugg

essing the prhs associate

tool to decrets of performOctober 1, 2eported by 6veraged recee has been aes dispenseeen a 44.3 p

controlled su

r providers or

not misusing p

tient was doct ("narcotics c

prescriptions

criptions to noprescriptions

ssed patient f

ubstance abu

ded for pain m

other psychiatm

eport to Law E

efused to fill a

mber of respo

onclusion

ublic health tool for curtdiversion. Tccessories tol professionathey emerge

e implementased Personsgests E-FORrescription ded with oxyco

ease prescrmance meas2011 through6,071 dispeneiving 5.07 pa 4.5 percened from 1,42percent redu

ubstance use

r pharmacies

prescriptions

ctor shoppingcontract" with

patient) for a patient

on-controlled for a patient

from practice

se treatment

management

tric disorder) management

Other

Enforcement

a prescription

Totalsndents becau

of all peopletailing one oThe PDMP ho the abuse als recommee to assist la

ation of E-FOs by Florida MRCSE® is impdrug abuse eodone use.4

iption drug asures reporteh Septembensers for 6,66prescriptions

nt decrease i1,855,076 dction in the t

Frequenc

68

50

66

48

10

33

14

23

9

14

7

3491use some res

e in Florida, of Florida’s ghelps to: (1)

of these preend appropraw enforcem

ORCSE®.39 Medical Exaproving the

epidemic by 0,41

abuse and ded during Ocr 30, 2012. 62,422 uniqs, a decreasin the total n

doses to 1,35total numbe

y Percen

82 19.5

05 14.4

69 19.

80 13.7

03 2.9

38 9.6

44 4.1

39 6.8

92 2.6

49 4.2

70 2.0

5 0.1

6 0.1

9 0.2

1* 100.0spondents sel

DOH is uniqravest threaprevent docescription drriate treatme

ment to identi

Evidence froaminers 2012prescribing oreducing do

iversion mayctober 1, 201There have ue patients,

se from 5.11number of do58,397,243 r of doses o

24 

 

nt

54%

47%

16%

75%

95%

68%

12%

85%

64%

27%

01%

14%

17%

26%

00%lected

quely ats to tors rugs; ent fy

om 2 of

octor

y be 12

the

oses

of

 

schedulefive or mfive contrreported fifth rankpercent) 1,388,65substantoxycodon

Drugs Idedeaths capercent wprescriptthe samereceivingperiod.

Althoughthan 6.4 percent aeverydaymaking to

In responrespondeshould bethe potenacknowlepurposespublic’s nstatistics

E-FORCdoctor shcontrolled

e II controlledore dispenserolled substato E-FORCSed controlledin the total n

50 prescriptioiates E-FORne.

entified in Daused by oxwhen compaion drugs, o

e period, theg prescription

h its use is nomillion times

and utilizatioy clinical praool to reduce

nse to the suents believede mandatoryntial for drugedge a legals.42 Pharmacnotion that pshow that d

SE® has prohopping andd substance

d substanceers in a yearances dispenSE®. Out od substancenumber of prons this yearRCSE® is imp

eceased Pexycodone pluared to 2011xycodone an

e PDMP docuns from five

ot mandators and througon increasedctice. This de prescriptio

urvey condud they needey. Many phyg diversion, r obligation tocists as well

prescription ddrug-induced

oven to be a controlled s

es.

s dispensedr from 15,09nsed makesf the top twe

e and has serescriptions r. The positproving the p

ersons by Flounged 41 pe. In additionnd methadoumented a 5or more pre

ry, physiciangh educationd 61 percent demonstrateon drug abus

cted by DOHed to registeysicians survrecognize tho minimize tas physicia

drugs represd morbidity a

critical tool substance re

d to individua94,444 dosess up 94.04 peenty-five, oxyeen the great

dispensed five results sprescribing o

orida Medicaercent in 201n, prescriptione, fell by 24

51 percent dscribers and

s and pharmnal efforts, E

suggesting es the value se, misuse a

H of the PDMer and utilizeveyed by DOe warning sithe use of prns thought t

sent a safe aand mortality

in the fight telated deaths

als visiting fivs to 8,402,27ercent of all ycodone hydtest percentfrom 1,822,1seen in the pof controlled

al Examiners2, and overa

ons for two o4 percent an

decrease in td five or mor

macists have-FORCSE®

it is becominof the PDM

and diversion

MP registeree E-FORCSEOH believed igns of possrescription dthey should alternative toy continue to

to protect hes, while sup

ve or more p77 doses. Tcontrolled s

drochloride, tage of chan164 prescriptperformance d substances

s 2012 Repoall drug deaof the four mnd 8 percentthe number ore pharmacie

e queried E-registration ng an integrP as a clinicn.

ed users, theE® and thougthey needed

sible misusesdrugs for impbe proactive

o street drugo increase.43

ealth and safpporting legit

prescribers aThe top twensubstances

represents nge (-23.79 tions to measure da

s, specificall

ort, shows ths fell by 9.

most harmful t respectivelof individuales in a 90-da

FORCSE® mincreased 2

ral part of cal decision

e majority of ght its use d to be awars, and

proper e to defuse tgs, since 3

fety by reductimate use o

25 

 

and nty-

the

ata y

.9

y. In s ay

more 8

f the

re of

he

cing f

 

 

                  1 Leonard P10,availabl2 National Ihttp:www.d3 R. Gill Kehttp://www4 Letter frohttp://myflo5 Id. at 9. 6 Leonard Pat http://ww7 Act Effect8 Amy Pavhttp://articledatabase-p9 Alliance ohttp://wwwdates?orde10 PDMP Thttp://www11 PDMP T23, 2013, 112 Id. 13 Id. 14 Id. 15 Id. 16 Id. 17 Id. 18 Id. 19 Id. 20 Id.  

21 Division

22 Division

23 Florida FInvestigatio24 Fla. Dep(Sep 23, 20Drug-Repo

25 Id. at ii. 26 Thomas Assessmenhttp://www27 Id. 28 Nat’l AlliaEnforcemehttp://www29 PDMP T23, 2013, 130 Nicole JoHealth MarPlanning S31 Id at 3. 32 Id. at 1033 Id. at 10 

                       Paulozzi et al.,e at http://wwwInstitute on Drudrugabuse.gov/erlikowske, Res.whitehouse.gom Pam Bondi,

oridalegal.com/

Paulozzi et al, ww.cdc.gov/mmtive July 1, 200uk, Florida’s Pres.orlandosentprescription-druof States with P.pmpalliance.oer=field_pmp_oTraining & Tech.pdmpassist.or

Training & Tech10:00AM), http

of Medical Qua

of Medical QuaFusion Center, ons,” email me

p’t Law Enforce013, 10:00AM)

ort_Final.aspx 

Clark, John Eant of the Eviden.pdmpexcellen

ance for Modeent and Licensin.namsdl.org/do

Training & Tech10:00AM), httpones, Florida Prch 22, 2013-A

Services).

.

.

                    CDC Grand R

w.cdc.gov/mmwug Abuse, Pres/sites/default/fisponding to theov/ondcp/newsAttorney Gene

/webfiles.nsf/W

Drug Overdosemwr/preview/mm09, ch. 2009-19rescription Drutinel.com/2011-ug-monitoring-mPrescription Drurg/content/pmp

operational_vahnical Assistancrg/pdf/pmpproghnical Assistanc://www.pdmpas

ality Assurance

ality AssuranceFlorida Departssages, Novemment, Drugs Id), http://www.fd

adie, Patrick Knnce for Best Prce.org/sites/all

l State Drug Lang Entities-Staocuments/Unsohnical Assistanc://www.pdmpas

Prescription Drupril 15, 2013, a

Rounds: Prescrwr/preview/mmscription Drugsles/rrprescriptio

e Prescription Ds-releases-remaeral, to Fellow F

WF/KGRG-8T8L

e Deaths- Florimwrhtml/mm6098, 2009 Fla. Lug Database La-09-01/news/osmodel-state-drug Monitoring Pp-legislation-oplue&sort=descce Center, PDM

gramstatus2013ce Center, Pressist.org/conte

e Annual Repo

e Annual Repotment of Law Ember 2011 to Odentified in Decle.state.fl.us/C

nue, Peter Kreractices, 22 (Jul/pdfs/Brandeis

aws, Unsoliciteate Map (2012)olicitedDataRepce Center, Pressist.org/conteug Monitoring Pat 3, 1-137 (20

ription Drug Ovwrhtml/mm610

s: Abuse and Aon.pdf. Drug Abuse Eparks/senate-intFloridians (Apr L5K/$file/Presc

ida 2003-2009,026a1.htm. aws 1978, 198

aunches, (Sep s-prescription-dug-laws. Programs, PMPperational-. MP Program S3.pdf. scription Drug nt/prescription-

rt, 2012-2013.

rt, 2012-2013.Enforcement, “#October 2012.ceased Person

Content/getdoc/

iner, Gail Strickun 6, 2013, 10:s_PDMP_Repo

d PMP Reports, ports09122012scription Drug nt/prescription-Program E-FOR13), (on file at

verdoses- a U.S01a3.htm#fig1.ddiction (2011)

pidemic (2012),tl-narcotics-caur 2, 2012), avaicriptionDrugDiv

, 60(26)MMWR

81 (codified at F1, 2011), drug-monitorin

P Legislation &

Status Map (Oc

Monitoring Fre-drug-monitorin

# Individuals Au

ns by Florida M/79241c67-253

kler, Prescriptio15 PM) availab

ort.pdf. 

ts/Information t

2.pdf. Monitoring Fre-drug-monitorinRCSE Survey Fla. Dep’t of H

S. Epidemic, 61

), available at

, available at ucus-statementlable at

versionAndAbu

R 869, 869-872

Fla. Stat. § 893

ng-begins-2011

& Operational D

ctober 22, 2013

equently Askedng-frequently-a

uthorized to Co

Medical Examine3b-45eb-a238-1

on Drug Monitoble at

to Prescribers,

equently Askedng-frequently-aResults Floridaealth, Division

1(01), MMWR;

t-rx-drug-abuse

seRoadmap.pd

2, (2011), availa

3.055 (2009)).

0901_1_drug-

Dates, (2012), a

3, 10:15AM)

d Questions (Masked-question

onduct

ers 2012 Repo1a07cf4a2a0c/

oring Programs

Pharmacists, L

d Questions (Masked-questiona Department oof MQA, Strate

26 

 

e.

df

able

at

Mar. ns-faq.

ort, ii, 2012-

s: An

Law

Mar. ns-faq. of egic

 

                  34 Id. at 1235 Id. at 1836 Id. 37 Id. 38 2006 Na39 PresentaFla. Board 40 Fla. Dep41 Jones, s42 Id. at 86‐ 43 Id. at 86

                       . .

ational Drug Coation by Rebecof Pharmacy).

p’t Law Enforcesupra note 29 a‐100. 6‐100. 

                       

ontrol Strategy, cca Poston, Fla

ement Medical at 12.

                        

http://www.ncja. PDMP Manag

Examiners, sup

                       

jrs.gov/pdffilesger to the Flori

pra note 24.

                       

1/ondcp/21294ida Board of Ph

                       

40.pdf (last accharmacy (Jun.

                       

cessed May 2, 6, 2013) (on fi

27 

 

            

2011). le with